EXEL Exelixis, Inc. $EXEL Company Overview Stock

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
EXEL Exelixis, Inc. $EXEL Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=EXEL&...mp;yt0=Go!

Last Updated: 10/09/2015 20:07:06

Current Price and Quotes
Last Price 5.985
Previous Close 5.85 Open 5.84
Daily Range 5.76 - 5.99 52wk Range 1.26 - 6.80
Volume 2,923,251 Dividend N/A
Average Vol (30d) 6,317,029 Net Dividend Yield N/A




Financials
Period Ending Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Total Revenue 25,111 31,338 47,450 289,636
Cost of Revenue 2,043 1,118 - -
Gross Profit 23,068 30,220 47,450 289,636
Operating Expenses

Research and Development 189,101 178,763 128,878 156,836
Sales, General and Admin. 50,829 50,958 31,837 33,129
Non-Recurring Items 7,596 1,231 9,171 10,136
Other - - - -
Operating Income (224,458) (200,732) (122,436) 89,535
Income From Continuing Operations

Add'l Income/Expense Items 4,341 1,223 1,986 3,716
Earnings Before Interest and Tax (220,117) (199,509) (120,450) 93,251
Interest Expense 48,607 45,347 27,088 16,259
Earnings Before Tax (268,724) (244,856) (147,538) 76,992
Income Tax (182) (96) 107 1,295
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (268,542) (244,760) (147,645) 75,697
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (268,542) (244,760) (147,645) 75,697
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (268,542) (244,760) (147,645) 75,697

Recent News
Source
Oct 6, 2015 Premarket Gainers / Losers as of 9:10 am Seeking Alpha
Oct 6, 2015 Exelixis Announces Positive Overall Survival Results from Phase 3 Pivotal Trial of Cobimetinib in Combination with Vemurafenib in Patients with BRAF V600 Mutation-Positive Advanced Melanoma BUSINESS WIRE
Sep 30, 2015 Stock Movement Prior To Phase III Trial Releases: Penny Stocks Rise While Big Stocks Fall Seeking Alpha
Sep 29, 2015 Top 3 Trade Alert Ideas September 25: Exelixis's Cobimetinib, Merck For Dividends, Progenics Catalysts Seeking Alpha
Sep 25, 2015 Exelixis Announces Positive Results from METEOR Phase 3 Pivotal Trial of Cabozantinib in Advanced Renal Cell Carcinoma Presented at European Cancer Congress 2015 BUSINESS WIRE
Sep 25, 2015 European CHMP Adopts Positive Opinion for Cobimetinib in Combination with Vemurafenib for the Treatment of Advanced Melanoma BUSINESS WIRE
Sep 24, 2015 Technical Coverage on Stocks from Diverse Sectors - CME Group, Commerce Bancshares, Conatus Pharmaceuticals, Exelixis and CTI BioPharma PR NEWSWIRE
Sep 24, 2015 Exelixis Announces Key Senior Leadership Hires in Medical Affairs, Sales, and Marketing to Support Commercialization of Cabozantinib and Cobimetinib BUSINESS WIRE
Sep 22, 2015 Exelixis to Host Investor/Analyst Webcast During European Cancer Congress 2015 BUSINESS WIRE
Sep 21, 2015 Biotechnology Stocks Technical Study -- Exelixis, XOMA Corp., Enzon Pharma, Peregrine Pharma, and StemCells PR NEWSWIRE

1
2
3
4
5
6
7
8
next >

EXEL Exelixis, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=EXEL&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/EXEL/quote
Stock Chart http://www.otcmarkets.com/stock/EXEL/chart
Company Info http://www.otcmarkets.com/stock/EXEL/company-info
Recent News http://www.otcmarkets.com/stock/EXEL/news
Financials http://www.otcmarkets.com/stock/EXEL/financials
Filings and Disclosure http://www.otcmarkets.com/stock/EXEL/filings
Short Sales http://www.otcmarkets.com/stock/EXEL/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/EXEL/insider-transactions
Research Reports http://www.otcmarkets.com/stock/EXEL/research
Summary http://finance.yahoo.com/q?s=EXEL
Historical Prices http://finance.yahoo.com/q/hp?s=EXEL+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=EXEL
Basic Chart http://finance.yahoo.com/q/bc?s=EXEL+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=EXEL+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=EXEL+Headlines
Press Releases http://finance.yahoo.com/q/p?s=EXEL+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=EXEL+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=EXEL+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=EXEL+Industry
Major Holders http://finance.yahoo.com/q/mh?s=EXEL+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=EXEL+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=EXEL+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=EXEL
Balance Sheet http://finance.yahoo.com/q/bs?s=EXEL
Cash Flow http://finance.yahoo.com/q/cf?s=EXEL+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/EXEL
Market Watch http://www.marketwatch.com/investing/stock/EXEL
Bloomberg http://www.bloomberg.com/quote/EXEL:US
Morningstar http://quotes.morningstar.com/stock/s?t=EXEL
Bussinessweek http://investing.businessweek.com/research/st...icker=EXEL
Barchart http://www.barchart.com/quotes/stocks/EXEL
OTC Short Report http://otcshortreport.com/index.php?index=EXEL
Investopedia http://www.investopedia.com/markets/stocks/EXEL/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 18

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
ADI Global Faces Investor Investigation Over Major Write-Down

Updated Category News Views 83

Towering Goodwill Falls and Investor Scrutiny Well, let's dig into this mess ADI Global Distribution has found itself in. If you were hanging onto ADIG shares, your portfolio probably took quite the hit when they revealed a nasty $659 million goodwill write-down. Imagine opening up those financials and seeing about 62% of goodwill value wiped out overnight. Suddenly, that...

Continue Reading
First Horizon's $25M Bet: New Center Transforms Houston

Updated Category News Views 166

New Markets Tax Credits: A Game Changer First things first, if you're thinking this is some typical charitable write-off, think again. First Horizon Bank (NYSE: FHN) is deep in the mix of something pretty transformative in the world of finance and community support. They're not just throwing money at a problem and hoping it sticks. Nope, we're talking real strategy with a...

Continue Reading
JardogsHealth Taps Industry Titans for Growth Council

Updated Category News Views 202

JardogsHealth: A New Chapter with Strategic Insights You've got to admire when a company rounds up a top-tier brain trust. Such is the case with JardogsHealth, the healthcare AI outfit nestled in Hillsboro, Illinois, as they align their future alongside heavyweights who’ve maneuvered through multiple industries and come out thriving. Their brand-new council includes...

Continue Reading
WhiteHorse Set to Redeem Its 2028 Notes Completely

Updated Category News Views 98

WhiteHorse Finance Divests Its 7.875% Notes Well, WhiteHorse Finance is making some moves, folks. They're planning to redeem their 7.875% notes due in 2028, totaling a cool $34.5 million. This ain't just pocket change, especially with the way markets have been bobbing and weaving lately. The redemption is slated for December 15, 2026, when the notes will get delisted from...

Continue Reading
Optikos Secures CMMC Level 2, Eyeing Defense Market

Updated Category News Views 116

Optikos Levels Up with CMMC Certification In a world where cybersecurity threats are lurking around every corner, Optikos has just joined the rarefied ranks of the top 1% of U.S. defense suppliers by grabbing the CMMC Level 2 certification. Let me tell you, this isn't just some shiny badge for show; it's a gateway to big defense contracts. Crunching the Numbers Of the...

Continue Reading
vVARDIS Debuts on NYSE: Transforming Dental Care

Updated Category News Views 92

A New Chapter for Dental Tech Mark your calendars, folks. vVARDIS is stepping onto the New York Stock Exchange (NYSE) stage, waving the banner of NYSE:VVVV. Now, if you've ever sat in that squeaky dental chair feeling the dread of a drill, vVARDIS might just be the new hero in town. Founded by the dynamic duo, Dr. Haley and Dr. Goly Abivardi, they're on a mission to...

Continue Reading
AppLovin Faces Serious Investor Lawsuit Deadline

Updated Category News Views 162

Investors' Trust Shaken: The AppLovin Controversy Well, what do we have here? Another day, another hefty lawsuit coming down the pike. The spotlight’s on AppLovin Corporation (NASDAQ: APP), where the Hagens Berman law sharks are sniffing blood in the water over what they claim are federal securities law violations. The core of this legal storm swirls around AppLovin's...

Continue Reading
ACME's AI Innovation Shakes Up Filmmaking Scene

Updated Category News Views 63

The Game-Changer in Virtual Production You ever hear about the Grey Box™ phenomenon? Sounds like a sci-fi gizmo, right? Turns out, it's the real deal and ACME Media's been riding this revolutionary wave straight to the top of the film industry ladder. Their approach with this AI-driven gizmo isn't just about cutting-edge tech wizardry—it's reimagining how we shoot...

Continue Reading
Dana Concludes Tender Offers for Senior Notes

Updated Category News Views 124

An Investor's Glance at Dana's Strategic Moves Dana Incorporated (NYSE: DAN) just pulled a bold move with their tender offers, snapping up a hefty $357,873,000 in outstanding principal on their senior notes. This isn’t just pocket change; folks holding out for securities can feel the tension of watching big numbers get shuffled around. You gotta wonder, what's the play...

Continue Reading

Top 5 Most Recently Viewed Articles

American Psychological Foundation Celebrates First Direct Action Grant

Updated Category News Views 209

Celebrating the First Direct Action Visionary Grant Recipient The American Psychological Foundation (APF) is excited to announce a groundbreaking initiative aimed at supporting communities in urgent need of psychological care. The Direct Action Visionary Grant program is designed to empower psychologists and community organizations, providing them with the necessary...

Continue Reading
Ilegal Mezcal Launches Unique Reposado Caribbean Cask Finish

Updated Category News Views 189

Exciting New Release from Ilegal Mezcal Ilegal Mezcal is excited to unveil its latest creation, the Ilegal Reposado Caribbean Cask Finish. This limited-edition mezcal is a remarkable addition to the global mezcal landscape, showcasing a wonderful fusion of traditional craftsmanship and innovative distilling techniques. What Sets Ilegal Reposado Apart? This new offering is...

Continue Reading
NextPlat Gears Up for Q3 2026 Earnings Call

Updated Category News Views 84

NextPlat's Upcoming Financial Revelation November is shaping up to be a month of revelations for NextPlat Corp (NASDAQ:NXPL) as they prepare to spill the beans on their third-quarter 2026 financials. The number crunching wraps up at 8:30 a.m. Eastern on November 12, when the execs will host an investor conference call. The Details of the Big Day Coming to you live from...

Continue Reading
Hormel Foods Reports First Quarter Earnings and Revenue Insights

Updated Category News Views 146

Hormel Foods Corporation Reports First Quarter Earnings Hormel Foods Corporation (NYSE: HRL) has announced its first quarter earnings, showing a mixed performance in terms of organic sales growth. While shares were trading higher before the market opened, some key metrics caught the attention of investors and analysts alike. First Quarter Adjusted Earnings Per Share The...

Continue Reading
NYAM and Yale Collaborate for Innovative Climate Action

Updated Category News Views 194

NYAM and Yale Center on Climate Change Partnership Overview The New York Academy of Medicine (NYAM) and the Yale Center on Climate Change and Health are joining forces for an important summit focused on health systems and climate action. This event, titled 'Health Systems Implementing Climate Action 2025', promises to be a major gathering of health sector and business...

Continue Reading